SCHEMBL18364664

SCHEMBL18364664

CC(c1ccc2cc(O)ccc2c1)c1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 3/20 0.51
CCND1 P24385 3/20 0.51
KIF11 P52732 3/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
CASP6 P55212 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
AHR P35869 1/20 0.42
VDR P11473 1/20 0.41
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
PTPN1 P18031 1/20 0.40
MTNR1A P48039 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18374989 0.87 CDK4 (0.52) CDK4CCND1KIF11KMT2AMEN1
SCHEMBL18364663 0.81 KIF11 (0.57) KIF11KMT2AMEN1KDM4EALDH1A1
SCHEMBL11020997 0.77 TYR (0.56) KMT2AMEN1HSD17B10CYP1A2
SCHEMBL18364666 0.77 HTR2A (0.48) KMT2AMEN1GAATDP1ALDH1A1
SCHEMBL29682540 0.77 KMT2A (0.72) CDK4CCND1KIF11KMT2AMEN1
SCHEMBL1182143 0.77 KMT2A (0.72) CDK4CCND1KIF11KMT2AMEN1
SCHEMBL13010630 0.75 KIF11 (0.79) KIF11KMT2AMEN1GAAKDM4E
SCHEMBL31549973 0.75 KIF11 (0.79) KIF11KMT2AMEN1GAAKDM4E
SCHEMBL21202512 0.74 CDK4 (0.44) CDK4CCND1KMT2AMEN1POLB
SCHEMBL6484779 0.74 KIF11 (0.49) CDK4CCND1KIF11KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170008843-A1 MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2017-01-12 US disclosed
US-20170008843-A1 MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2017-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170008843-A1 MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS MSMO1, NOM1, CD68 CDK4 682/4885CCND1 365/4885KIF11 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.